arXiv.itsnick.co

an independent field guide to 23 million papers from arXiv & OpenAlex — not affiliated with arXiv.org

Author

Mutation Sn

1 paper · 2013–2013

2013: 1
2013peak 1 in 20132013

Frequent co-authors

Papers

showing 1–1 of 1 RSS

CHEST Selected Reports 1376 Selected Reports Normalization of Sweat Chloride Concentration and Clinical Improvement With Ivacaftor in a Patient With Cystic Fibrosis With

Mutation Sn, Meghan E. Mcgarry, Dennis W. Nielson

Linguistics and Language · · cited 0× · OpenAlex ↗ · more like this ·

The cystic fi brosis (CF) protein forms an anion channel in epithelial cells, and the absence or defective func-tion of this channel results in the clinical manifesta-tions of CF. CF is an autosomal recessive disorder, and its many disease-causing mutations divide into fi ve or six classes. There are 10 known class 3 gating muta-tions, the most common of which is G551D. Ivacaftor is a drug that in vitro increases open time and trans-epithelial chloride transport in all 10 gating mutations, but it is approved for use only in patients with the G551D mutation. We report complete normalization of sweat chloride concentration and rapid clinical improvement over 6 weeks of treatment with ivacaftor in a patient with CF with the gating mutation S549N. The fi ndings suggest that ivacaftor should be consid-